RPE65

Results: 8



#Item
1Vision Improvement After Retreatment with an Oral Synthetic cis-Retinoid (QLT091001) in Subjects with Inherited Retinal Disease caused by Mutations in RPE65 or LRAT On behalf of the RET IRD 02 Study Group:  Hendrik P.N.

Vision Improvement After Retreatment with an Oral Synthetic cis-Retinoid (QLT091001) in Subjects with Inherited Retinal Disease caused by Mutations in RPE65 or LRAT On behalf of the RET IRD 02 Study Group: Hendrik P.N.

Add to Reading List

Source URL: www.qltinc.com

Language: English - Date: 2015-06-06 02:10:51
    2Microsoft Word - IRDDNA140821.doc

    Microsoft Word - IRDDNA140821.doc

    Add to Reading List

    Source URL: www.scgh.health.wa.gov.au

    Language: English - Date: 2014-08-28 04:22:42
    3Molecular Vision 2013; 19:[removed] <http://www.molvis.org/molvis/v19/2312> Received 31 July 2013 | Accepted 14 November 2013 | Published 16 November 2013 © 2013 Molecular Vision  Retinal pigment epithelium protein of 6

    Molecular Vision 2013; 19:[removed] Received 31 July 2013 | Accepted 14 November 2013 | Published 16 November 2013 © 2013 Molecular Vision Retinal pigment epithelium protein of 6

    Add to Reading List

    Source URL: www.molvis.org

    Language: English - Date: 2013-11-16 12:00:51
    4Identifying photoreceptors in blind eyes caused by RPE65 mutations: Prerequisite for human gene therapy success Samuel G. Jacobson*†, Tomas S. Aleman*, Artur V. Cideciyan*, Alexander Sumaroka*, Sharon B. Schwartz*, Eli

    Identifying photoreceptors in blind eyes caused by RPE65 mutations: Prerequisite for human gene therapy success Samuel G. Jacobson*†, Tomas S. Aleman*, Artur V. Cideciyan*, Alexander Sumaroka*, Sharon B. Schwartz*, Eli

    Add to Reading List

    Source URL: www.pnas.org

    Language: English - Date: 2011-08-19 00:43:09
    5Media	
  Inquiries:	
  	
   Jessica	
  Rowlands	
   202-­‐729-­‐4089	
   [removed]	
   	
   Spark	
  Therapeutics	
  Receives	
  FDA	
  Breakthrough	
  Therapy	
  Designation	
  f

    Media  Inquiries:     Jessica  Rowlands   202-­‐729-­‐4089   [removed]     Spark  Therapeutics  Receives  FDA  Breakthrough  Therapy  Designation  f

    Add to Reading List

    Source URL: www.sparktx.com

    Language: English - Date: 2014-11-25 08:45:10
    6Media Inquiries: Jessica Rowlands[removed]removed]  Spark Therapeutics Raises $72.8 Million in Oversubscribed Financing

    Media Inquiries: Jessica Rowlands[removed]removed] Spark Therapeutics Raises $72.8 Million in Oversubscribed Financing

    Add to Reading List

    Source URL: www.sparktx.com

    Language: English - Date: 2014-05-27 14:36:51
    7RETINITIS PIGMENTOSA RESEARCH ADVANCES Landmark Gene Therapy Restores Vision in Children and Young Adults More than 40 children and young

    RETINITIS PIGMENTOSA RESEARCH ADVANCES Landmark Gene Therapy Restores Vision in Children and Young Adults More than 40 children and young

    Add to Reading List

    Source URL: www.blindness.org

    Language: English - Date: 2014-09-23 13:27:53
    8Molecular Vision 2003; 9:601-5 <http://www.molvis.org/molvis/v9/a73> Received 17 July 2003 | Accepted 24 October 2003 | Published 11 November 2003

    Molecular Vision 2003; 9:601-5 Received 17 July 2003 | Accepted 24 October 2003 | Published 11 November 2003

    Add to Reading List

    Source URL: www.molvis.org

    Language: English - Date: 2011-04-21 16:15:33